Is Medtech finally ready to capitalize on the promise of connectivity?
For years, medtech companies have known connectivity was good for them, but the promise of data streaming through devices didn't match the reality. COVID-19 changed that, creating an opportunity for device companies with connectivity plans in place.
In this episode, we speak with Dr. David Hayes, CMO of Biotronik, about that companies success in connecting cardiology patients. Meanwhile, Bill Betten of S3 Connected Health explains what device companies must do to prepare for medtech's next age.
We also review the week's top news involving Medtronic, Johnson & Johnson, Abbott, Edwards, and Smith+Nephew
In this episode, we speak with Dr. David Hayes, CMO of Biotronik, about that companies success in connecting cardiology patients. Meanwhile, Bill Betten of S3 Connected Health explains what device companies must do to prepare for medtech's next age.
We also review the week's top news involving Medtronic, Johnson & Johnson, Abbott, Edwards, and Smith+Nephew
Activity